Last reviewed · How we verify
Sofosbuvir, Sovaldi
Sofosbuvir, Sovaldi is a Small molecule drug developed by Tarek I. Hassanein, M.D., FACP, FAG, AGAF. It is currently FDA-approved. Also known as: SOF.
At a glance
| Generic name | Sofosbuvir, Sovaldi |
|---|---|
| Also known as | SOF |
| Sponsor | Tarek I. Hassanein, M.D., FACP, FAG, AGAF |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents (PHASE4)
- A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients (PHASE2)
- Implementing Low-Barrier HCV Treatment in a Jail Setting (PHASE4)
- Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients (NA)
- Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy (PHASE4)
- Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients (PHASE2)
- C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV (PHASE3)
- SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sofosbuvir, Sovaldi CI brief — competitive landscape report
- Sofosbuvir, Sovaldi updates RSS · CI watch RSS
- Tarek I. Hassanein, M.D., FACP, FAG, AGAF portfolio CI
Frequently asked questions about Sofosbuvir, Sovaldi
What is Sofosbuvir, Sovaldi?
Sofosbuvir, Sovaldi is a Small molecule drug developed by Tarek I. Hassanein, M.D., FACP, FAG, AGAF.
Who makes Sofosbuvir, Sovaldi?
Sofosbuvir, Sovaldi is developed and marketed by Tarek I. Hassanein, M.D., FACP, FAG, AGAF (see full Tarek I. Hassanein, M.D., FACP, FAG, AGAF pipeline at /company/tarek-i-hassanein-m-d-facp-fag-agaf).
Is Sofosbuvir, Sovaldi also known as anything else?
Sofosbuvir, Sovaldi is also known as SOF.
What development phase is Sofosbuvir, Sovaldi in?
Sofosbuvir, Sovaldi is FDA-approved (marketed).
Related
- Manufacturer: Tarek I. Hassanein, M.D., FACP, FAG, AGAF — full pipeline
- Also known as: SOF
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing